 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Tilton John
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-03-12 Sale | 2019-03-14 5:51 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 10,000 | $50.11 | $501,100 | 78,792 (Indirect Direct) | View |
| 2019-01-10 Sale | 2019-01-14 5:50 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 10,500 | $37.67 | $395,535 | 10,500 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-11-25 Option Award | 2019-11-27 9:31 pm | N/A 2029-11-24 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John CCO-Rare & Neurologic Disorder | 10,000 | $57.4 | 10,000 (Direct) | View |
| 2019-11-25 Option Award | 2019-11-27 9:31 pm | N/A 2022-11-24 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John CCO-Rare & Neurologic Disorder | 5,000 | $0 | 10,000 (Direct) | View |
| 2019-03-12 Exercise | 2019-03-14 5:51 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 10,000 | $9.29 | 78,792 (Direct) | View |
| 2019-03-12 Exercise | 2019-03-14 5:51 pm | N/A 2027-01-30 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 10,000 | $9.29 | 78,792 (Direct) | View |
| 2019-01-10 Exercise | 2019-01-14 5:50 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 10,500 | $9.29 | 10,500 (Direct) | View |
| 2019-01-10 Exercise | 2019-01-14 5:50 pm | N/A 2026-12-14 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 10,500 | $9.29 | 10,500 (Direct) | View |
| 2017-12-07 Option Award | 2017-12-11 5:37 pm | N/A 2027-12-06 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 21,740 | $20.79 | 21,740 (Direct) | View |